Skip to main content

Table 6 Relative size of incentive payments to revenue

From: Is the evidence on the effectiveness of pay for performance schemes in healthcare changing? Evidence from a meta-regression analysis

Scheme, study

Country

Payment/Revenue (%)

Spontaneous breathing trials (SBTs), [8]

US

7.5

CAPI-ROSP, [9,10,11]

France

4–7

Rwanda P4P, [12]

Rwanda

22

P4P for Maternal care, [13,14,15]

Tanzania

10–25

P4P for Antibiotics, [16]

Sweden

0.05–1.2

Quality and Outcomes Framework, [17]

UK

25

Afghanistan P4P, [18]

Afghanistan

6–28